MiMedx Group, Inc (MDXG) is a publicly traded Healthcare sector company. As of July 21, 2026, MDXG trades at $4.29 with a market cap of $640.47M and a P/E ratio of 19.61. MDXG moved -1.39% today. Year to date, MDXG is -36.88%; over the trailing twelve months it is -32.55%. Its 52-week range spans $3.03 to $10.14. Analyst consensus is strong buy with an average price target of $6.33. Rallies surfaces MDXG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MDXG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $4.29 |
| Market Cap | $640.47M |
| P/E Ratio | 19.61 |
| EPS | $0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.14 |
| 52-Week Low | $3.03 |
| Volume | 414.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $389.42M |
| Net Income | $30.70M |
| Gross Margin | 81.04% |
4 analysts cover MDXG: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.33.